Thread
:
'Modest support' for PFS as OS surrogate in HER2-positive metastatic breast cancer
View Single Post
03-22-2016, 10:21 PM
#
1
News
Senior Member
Join Date: Oct 2007
Posts: 19,011
'Modest support' for PFS as OS surrogate in HER2-positive metastatic breast cancer
Progression-free survival only moderately correlates with overall survival at the individual and trial level in patients with HER2-positive metastatic breast cancer treated with HER2-targeted agents, say researchers.
More...
News
View Public Profile
Send a private message to News
Find More Posts by News